Investigation and regulation of molecular mechanisms of epithelial mesenchymal transition in pulmonary fibrosis
肺纤维化上皮间质转化分子机制的研究与调控
基本信息
- 批准号:17590793
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Epithelial-mesenchymal transition (EMT) has been considered to be involved in organ fibrogenesis. However, there is few direct evidence of this process in the pathophysiology of pulmonary fibrosis in vivo. Therefore, we tried to verify the involvement of this process in the development of pulmonary fibrosis. Since the co-expressions of epithelial and mesenchymal markers are thought to be a marker of EMT, we performed dual immunohistochemistry to assess the co-expressions of these proteins in lung tissues from bleomycin-induced pulmonary fibrosis in mice, and from patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Double positive cells for epithelial markers including E-cadherin, CD44v10,T1α, or aquaporin 5,and a mesenchymal marker α-smooth muscle actin were rarely found in bleomycin-induced pulmonary fibrosis in mice. Double positive cells for E-cadherin, ICAM-1,LEA, CD44v9,or SP-A and a-smooth muscle actin were not found in lung tissues from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. In contrast to few incidence of EMT, we occasionally found intermediate cells which have characteristics of type I and type II or bronchiolar epithelial cells. These results suggest that EMT may be present in pulmonary fibrosis, but have minor role in the pathophysiology of pulmonary fibrosis.
上皮间质转化(EMT)被认为参与器官纤维发生。然而,在体内肺纤维化的病理生理学中,很少有直接证据表明这一过程。因此,我们试图验证这一过程是否参与肺纤维化的发展。由于上皮和间质标记物的共表达被认为是 EMT 的标记物,因此我们进行了双重免疫组织化学来评估这些蛋白质在博来霉素诱导的小鼠肺纤维化以及特发性肺纤维化和非特异性间质性肺炎患者的肺组织中的共表达。在博莱霉素诱导的小鼠肺纤维化中,很少发现上皮标记物(包括 E-钙粘蛋白、CD44v10、T1α 或水通道蛋白 5)和间充质标记物 α-平滑肌肌动蛋白双阳性细胞。特发性肺纤维化和非特异性间质性肺炎肺组织中未发现E-钙粘蛋白、ICAM-1、LEA、CD44v9或SP-A和α-平滑肌肌动蛋白双阳性细胞。与很少发生的EMT相反,我们偶尔发现具有I型和II型或细支气管上皮细胞特征的中间细胞。这些结果表明EMT可能存在于肺纤维化中,但在肺纤维化的病理生理学中作用较小。
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Editorials. PTEN as a new agent in the fight against fibrogenesis.
社论。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Burioka N;et. al.;Kuwano K
- 通讯作者:Kuwano K
Doxycycline attenuates puimonary fibrosis induced by bleomycin in mice
多西环素减轻博莱霉素诱导的小鼠肺纤维化
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Fujita M;Kuwano K;et al.
- 通讯作者:et al.
Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice
- DOI:10.4049/jimmunol.175.2.1224
- 发表时间:2005-07-15
- 期刊:
- 影响因子:4.4
- 作者:Hamada, N;Kuwano, K;Nakanishi, Y
- 通讯作者:Nakanishi, Y
Gene transfer of soluble transforming growth factor type II receptor by in vivo electroporation attenuates lung injury and fibrosis
通过体内电穿孔进行可溶性转化生长因子 II 型受体的基因转移可减轻肺损伤和纤维化
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Yamada M;et. al.
- 通讯作者:et. al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KUWANO Kazuyoshi其他文献
KUWANO Kazuyoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KUWANO Kazuyoshi', 18)}}的其他基金
The significance of signaling pathways by exososme in lung injury and fibrosis
外泌体信号通路在肺损伤和纤维化中的意义
- 批准号:
24591178 - 财政年份:2012
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Relation of the quality of seawater to the decline of seaweed populations
海水质量与海藻种群减少的关系
- 批准号:
22580379 - 财政年份:2010
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms and roles of cell senescence in lung injury and repair
细胞衰老在肺损伤和修复中的分子机制和作用
- 批准号:
21591004 - 财政年份:2009
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of small airways in lung injury and regeneration, and the treatment strategy using nanotechnology
小气道在肺损伤和再生中的作用以及纳米技术的治疗策略
- 批准号:
19390225 - 财政年份:2007
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Involvement of ER stress in the molecular mechanisms of lung injury and pulmonary fibrosis
内质网应激参与肺损伤和肺纤维化的分子机制
- 批准号:
15590815 - 财政年份:2003
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Ubiquitin-proteasome system in the molecular mechanisms of lung injury and pulmonary fibrosis
泛素-蛋白酶体系统在肺损伤和肺纤维化分子机制中的作用
- 批准号:
13670604 - 财政年份:2001
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Bronchiolar and alveolar epithelial cell apoptosis in pulmonary fibrosis
肺纤维化中细支气管和肺泡上皮细胞凋亡
- 批准号:
09670620 - 财政年份:1997
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
The role of epigenetic regulator UHRF1 in stability of induced regulatory T-cell function during influenza A virus-induced lung injury
表观遗传调节因子 UHRF1 在甲型流感病毒诱导的肺损伤过程中诱导调节 T 细胞功能稳定性中的作用
- 批准号:
10389878 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Mechanisms Regulating Lung Injury and Early Lung Fibrosis
肺损伤和早期肺纤维化的调节机制
- 批准号:
10627593 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
1/2: PREcision VENTilation to attenuate Ventilation-Induced Lung Injury (PREVENT VILI)
1/2:精确通气以减轻通气引起的肺损伤(预防 VILI)
- 批准号:
10738958 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Role of neonatal lung macrophages in mediating resilience to hyperoxia induced lung injury via TREM2 signaling
新生儿肺巨噬细胞通过 TREM2 信号传导介导高氧诱导肺损伤的恢复能力
- 批准号:
10720557 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:














{{item.name}}会员




